Diagnosis of post-traumatic stress disorder (PTSD) is complicated by overlapping and confounding symptoms. Patients often fail to elaborate on these symptoms. How can you effectively treat or refer patients for treatment of PTSD if diagnosis is so difficult? Validated screening tools can help! Learn about these tools and how to use them from Drs. Joseph Goldberg and Roger McIntyre.
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
Introduction
Post-traumatic stress disorder (PTSD) is a severe and highly impactful mental health condition that frequently affects women and often stems from traumatic experiences such as violence or abuse.1 However, studies have shown that women are at a higher risk of developing PTSD compared to men, making the recognition, diagnosis, and treatment of PTSD in this population a significant healthcare issue.2,3 This summary explores the epidemiology and symptomatology of PTSD, as well as the challenges in diagnosis, impact of stigma, and importance of empathy and effective communication when treating women with PTSD, particularly in primary care and obstetrics-gynecology (OB-GYN) settings.
Epidemiology and Prevalence of PTSD in Women
Studies have consistently shown that women are more susceptible to trauma and PTSD than men. Research suggests that up to 50% of women are exposed to at least one traumatic event in their lifetime, and approximately 20% experience trauma of a sexual or violent nature.4 In the general population, the prevalence of PTSD is estimated to be 3%-4%, with women being twice as likely to develop PTSD compared to men, resulting in a prevalence rate of about 8% for women versus 4% for men.5 This heightened risk can be attributed to the nature and frequency of trauma exposure in women, with factors such as childhood abuse, domestic violence, and interpersonal violence contributing significantly to the development of PTSD.
Challenges in Recognizing PTSD in Women
One of the major challenges in addressing PTSD in women is the delay in detection and diagnosis. Many patients experience a significant lag between the onset of symptoms and receiving a formal diagnosis.6 Several factors contribute to this delay, including low levels of awareness and unfamiliarity with PTSD diagnostic criteria among healthcare professionals.7,8 This lack of awareness can lead to a failure to ask about trauma histories or recognize the broad range of PTSD symptoms, resulting in missed opportunities for early diagnosis and intervention.
It is critical for clinicians to recognize that women with PTSD may present with a wide array of symptoms that extend beyond the classic signs of hyperarousal and nightmares.9 Commonly reported symptoms in women include mood disturbances, irritability, and anger, which often lead to a misdiagnosis of other psychiatric conditions such as mood or personality disorders.10,11 Other manifestations such as chronic pain, sleep dysregulation, self-harm, and suicidal ideation can also be indicative of PTSD; however, these symptoms may be overlooked or attributed to other physical or mental health causes.
The Role of Stigma and Self-Stigma in PTSD
Stigma, both external and internal, plays a substantial role in the underdiagnosis and undertreatment of PTSD in women. Many women may feel ashamed or guilty about their traumatic experiences, especially when these experiences involve familial or sexual abuse.12 This sense of shame can prevent them from disclosing their trauma or seeking help, leading to a delay in diagnosis and treatment. The concept of self-stigma can be particularly detrimental, as women may internalize negative beliefs about themselves and feel as though they should simply "shake off" the trauma or that their responses are somehow a sign of weakness.
Educational efforts are needed to emphasize that PTSD is not a sign of personal failure or maladaptation but rather a condition that arises from a complex interplay of biological susceptibility and environmental factors. This understanding can help reduce the stigma associated with PTSD and encourage more women to seek help and support.
Differential Diagnosis of PTSD
When evaluating patients who have experienced trauma, it is essential to consider a broad differential diagnosis beyond just PTSD. Conditions such as substance use disorders, major depression, bipolar disorder, and adjustment disorders can present with overlapping symptoms and may also develop in response to trauma. Clinicians should be mindful of these potential diagnoses to ensure comprehensive screening and avoid the misattribution of symptoms solely to PTSD. Referral to a psychiatrist is recommended when symptoms are complex, severe, or unresponsive to initial interventions, recognizing that PTSD often requires expertise beyond that of a general practitioner.
Impact of Trauma on Quality of Life and Functioning
PTSD can have a profound impact on a woman's quality of life, affecting social, interpersonal, and occupational functioning.13 Women with PTSD often experience difficulty maintaining relationships, fulfilling work responsibilities, and engaging in daily activities. The lingering effects of trauma can result in persistent emotional distress, decreased productivity, and impaired psychosocial functioning.14 These effects can be further compounded by comorbid conditions such as depression, anxiety, and substance use disorders, making the management of PTSD more challenging.
Addressing the Complexity of PTSD Diagnosis
Diagnosing PTSD can be extremely complex due to the overlap of symptoms with other psychiatric disorders. The differential diagnosis for women presenting with mood disturbances, irritability, and other symptoms can be broad and include mood, personality, and substance use disorders.15,16 It is crucial for clinicians to screen for PTSD, especially in women with a history of trauma, and to utilize validated screening tools such as the PTSD Checklist for DSM-5 (PCL-5) or the Primary Care PTSD Screen (PC-PTSD).
A thorough assessment should include questions about intrusive thoughts, hyperarousal, mood and cognitive symptoms, and avoidance behaviors, which are hallmark features of PTSD.15 Given the potential for symptom overlap, clinicians must carefully distinguish between PTSD and other conditions to ensure accurate diagnosis and appropriate treatment.
Screening and Early Detection in Primary Care and OB-GYN Settings
Primary care and OB-GYN settings present valuable opportunities for the early detection and intervention of PTSD in women. Given the frequency with which women seek care in these settings, clinicians should routinely ask about trauma histories as part of a comprehensive assessment. A simple, cost-effective question such as, "Have you ever experienced any traumatic events?" can serve as a gateway to uncovering potential PTSD.
For women who screen positive for trauma, clinicians should proceed with more detailed inquiries about their symptoms and use standardized screening tools to guide the evaluation. It is essential to recognize that even if a patient is not ready to disclose the details of their trauma, screening for PTSD-related symptoms, such as sleep disturbances, intrusive thoughts, or avoidance behaviors, can provide valuable insights into their condition.
Importance of Empathy and Effective Communication
Empathy plays a central role in building trust and facilitating the disclosure of trauma among women with PTSD. Many women may be reluctant to discuss their trauma due to feelings of shame, guilt, or fear of judgment. Therefore, it is imperative for clinicians to approach the topic with sensitivity and a nonjudgmental attitude. Using open-ended questions, requesting permission to discuss sensitive topics, and acknowledging the patient's comfort level can help create a safe environment for sharing traumatic experiences.
For example, instead of directly probing about traumatic events, a clinician might ask, "Is it okay if I ask about any difficult experiences you may have had in the past?" This approach allows patients to feel in control of the conversation and more willing to share their history. It is also important to validate the patient's emotions and experiences by reinforcing that their responses to trauma are understandable and that help is available.
Overcoming Barriers to Diagnosis and Treatment
Several barriers can hinder the timely diagnosis and treatment of PTSD in women, including self-stigma, limited awareness of PTSD among healthcare providers, and disparities in access to care. For marginalized groups, such as women of color or those with limited socioeconomic resources, these barriers can be even more pronounced.17 Clinicians must be cognizant of these disparities and work to ensure that all women, regardless of their background, receive the care they need.
Education regarding the biological basis of PTSD, as well as the availability of effective treatments, can help reduce stigma and encourage more women to seek help. Moreover, understanding that PTSD can coexist with other psychiatric conditions, such as depression, emphasizes the importance of comprehensive treatment approaches that address both conditions simultaneously.
The Role of Evidence-Based Treatments
Effective treatments for PTSD in women include both pharmacological and non-pharmacological interventions. Behavioral therapies, particularly trauma-focused cognitive behavioral therapy (CBT), have shown strong evidence in reducing PTSD symptoms.18 Pharmacological treatments, such as selective serotonin reuptake inhibitors (SSRIs) and a combination of an SSRI (sertraline) and an atypical antipsychotic (brexpiprazole), can also be beneficial, especially for patients with comorbid depression or anxiety.19,20
Clinicians should always take a collaborative approach and involve patients in treatment decisions. Educating women about the effectiveness of treatment options can empower them to engage in their care and adhere to treatment recommendations.
Conclusion
PTSD is a prevalent and often underdiagnosed condition in women that has far-reaching implications for quality of life, mental health, and overall well-being. Recognizing the diversity of symptoms, addressing stigma, and utilizing empathetic communication strategies are essential components of effective care. Primary care and OB-GYN clinicians play a crucial role in identifying women at risk for PTSD, initiating appropriate screening, and facilitating timely referrals to mental health specialists. By fostering a culture of empathy, awareness, and collaboration, healthcare providers can help women affected by PTSD receive the support and treatment they need to heal and recover.
References
1. Yehuda R, Hoge CW, McFarlane AC, et al. Post-traumatic stress disorder. Nat Rev Dis Primers. 2015;1:15057.
2. Yazawa A, Aida J, Kondo K, Kawachi I. Gender differences in risk of posttraumatic stress symptoms after disaster among older people: differential exposure or differential vulnerability? J Affect Disord. 2022;297:447-454.
3. Olff M. Sex and gender differences in post-traumatic stress disorder: an update. Eur J Psychotraumatol. 2017;8(sup4):1351204.
4. U.S. Department of Health and Human Services. A Treatment Improvement Protocol - Trauma-Informed Care in Behavioral Health Services - Tip 57.Substance Abuse and Mental Health Services Administration; 2014.
5. Post-traumatic stress disorder (PTSD). National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/statistics/post-traumatic-stress-disorder-ptsd
6. Thompson JM, Heber A, Davine J, Murray R, McCreary DR. Recognizing posttraumatic stress disorder in primary care. In: Ricciardelli R, Bornstein S, Hall A, Carleton RN, eds. Handbook of Posttraumatic Stress. Routledge; 2021.
7. Arnaoudova A, Aleksandrov I, Stoyanov V, Ivanova V, Petrov PY. Diagnostic challenges in assessing post-traumatic stress disorder. J of IMAB. 2015;21:987-990.
8. Armstrong K. Complex, puzzling, ill-defined: challenges in assessing PTSD. Applied Clinical Trials. October 10, 2018. https://www.appliedclinicaltrialsonline.com/view/complex-puzzling-ill-defined-challenges-assessing-ptsd
9. James S. Women’s experiences of symptoms of posttraumatic stress disorder (PTSD) after traumatic childbirth: a review and critical appraisal. Arch Womens Ment Health. 2015;18(6):761-771.
10. Kemp A, Rawlings EI, Green BL. Post-traumatic stress disorder (PTSD) in battered women: a shelter sample. J Traumatic Stress. 1991;4(1):137-148.
11. Vitanza S, Vogel LCM, Marshall LL. Distress and symptoms of posttraumatic stress disorder in abused women. Violence Vict. 1995;10(1):23-34.
12. Krzemieniecki A, Gabriel KI. Stigmatization of posttraumatic stress disorder is altered by PTSD knowledge and the precipitating trauma of the sufferer. J Ment Health. 2021;30(4):447-453.
13. Balayan K, Kahloon M, Tobia G, et al. The impact of posttraumatic stress disorder on the quality of life: a systematic review. Int Neuropsychiatr Dis J. 2014;2(5):214-233.
14. Holbrook TL, Hoyt DB. The impact of major trauma: quality-of-life outcomes are worse in women than in men, independent of mechanism and injury severity. J Trauma. 2004;56(2):284-290
15. Bryant RA. Post-traumatic stress disorder: a state-of-the-art review of evidence and challenges. World Psychiatry. 2019;18(3):259-269.
16. Frommberger U, Angenendt J, Berger M. Post-traumatic stress disorder--a diagnostic and therapeutic challenge. Dtsch Arztebl Int. 2014;111(5):59-65.
17. Ford JD. Ethnoracial minority background, psychological trauma, PTSD, and DESNOS among urban low-income women with severe mental illness. J Psychol Trauma. 2008;7:170-184.
18. Shubina I. Cognitive-behavioral therapy of patients with ptsd: literature review. Procedia - Soc Behav Sci. 2015;165:208-216.
19. O'Connor M. Adjunctive therapy with brexpiprazole improves treatment resistant complex post traumatic stress disorder in domestic family violence victims. Australas Psychiatry. 2020;28(3):264-266.
20. Huang ZD, Zhao YF, Li S, et al. Comparative efficacy and acceptability of pharmaceutical management for adults with post-traumatic stress disorder: a systematic review and meta-analysis. Front Pharmacol. 2020;11:559.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Joseph F. Goldberg, MD
Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, NYDr. Goldberg has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Receives royalties: American Psychiatric Publishing, Cambridge University Press?
Consulting Fees: AbbVie, Alkermes, Axsome, BioXcel, Intra-Cellular Therapies, Neumora, Neurelis, Otsuka, Sage Pharmaceuticals Sunovion, SupernusReviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Barry A. Fiedel, PhD, has nothing to disclose.
- Brian P. McDonough, MD, FAAFP, has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Apply validated, guideline-recommended screening tools to diagnose post-traumatic stress disorder (PTSD) in women
- Implement PTSD treatment guidelines into clinical practice to ensure evidence-based management
Target Audience
This activity has been designed to meet the educational needs of ob-gyns and primary care physicians, as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with post-traumatic stress disorder (PTSD).
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for .25 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .25 AAPA Category 1 CME credits. Approval is valid until November 15, 2025. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for .25 contact hours/.025 CEUs of pharmacy contact hours.
The Universal Activity Number for this program is JA0006235-0000-24-127-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).Provider(s)/Educational Partner(s)
It’s about time! Today’s on-the-go learners have minutes to spend on education instead of hours. Total CME is an award-winning, global healthcare education company that strategically pioneers methodology, initiatives, and platforms to meet these time-limited needs. Unlike other medical education companies, Total CME employs a microlearning approach and platform to create outcome-based curricula that motivates HCPs to engage in self-directed point-of-care learning that impacts change in real time. Even while reaching the largest global distribution, we provide the most personalized, seamless learner experience. We’re meeting our busy learners where they are so they can focus on what they want when they need it, ultimately leading to behavior changes that impact clinical practice and empower patients in their own care.Commercial Support
This activity is supported by an independent educational grant from Otsuka America Pharmaceutical Inc. and Lundbeck, Inc.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Total CME, LLC you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyrightSystem Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Overview
Diagnosis of post-traumatic stress disorder (PTSD) is complicated by overlapping and confounding symptoms. Patients often fail to elaborate on these symptoms. How can you effectively treat or refer patients for treatment of PTSD if diagnosis is so difficult? Validated screening tools can help! Learn about these tools and how to use them from Drs. Joseph Goldberg and Roger McIntyre.
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Joseph F. Goldberg, MD
Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, NYDr. Goldberg has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Receives royalties: American Psychiatric Publishing, Cambridge University Press?
Consulting Fees: AbbVie, Alkermes, Axsome, BioXcel, Intra-Cellular Therapies, Neumora, Neurelis, Otsuka, Sage Pharmaceuticals Sunovion, SupernusReviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Barry A. Fiedel, PhD, has nothing to disclose.
- Brian P. McDonough, MD, FAAFP, has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Apply validated, guideline-recommended screening tools to diagnose post-traumatic stress disorder (PTSD) in women
- Implement PTSD treatment guidelines into clinical practice to ensure evidence-based management
Target Audience
This activity has been designed to meet the educational needs of ob-gyns and primary care physicians, as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with post-traumatic stress disorder (PTSD).
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for .25 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .25 AAPA Category 1 CME credits. Approval is valid until November 15, 2025. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for .25 contact hours/.025 CEUs of pharmacy contact hours.
The Universal Activity Number for this program is JA0006235-0000-24-127-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).Provider(s)/Educational Partner(s)
It’s about time! Today’s on-the-go learners have minutes to spend on education instead of hours. Total CME is an award-winning, global healthcare education company that strategically pioneers methodology, initiatives, and platforms to meet these time-limited needs. Unlike other medical education companies, Total CME employs a microlearning approach and platform to create outcome-based curricula that motivates HCPs to engage in self-directed point-of-care learning that impacts change in real time. Even while reaching the largest global distribution, we provide the most personalized, seamless learner experience. We’re meeting our busy learners where they are so they can focus on what they want when they need it, ultimately leading to behavior changes that impact clinical practice and empower patients in their own care.Commercial Support
This activity is supported by an independent educational grant from Otsuka America Pharmaceutical Inc. and Lundbeck, Inc.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Total CME, LLC you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyrightSystem Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?